Results 121 to 130 of about 1,885 (156)
Some of the next articles are maybe not open access.

Abstract 3043: Preclinical efficacy assessment of brincidofovir against glioblastoma

Cancer Research
Abstract Introduction: Clinical use of the cytidine-analogue antiviral, cidofovir (CDV), is limited by nephrotoxicity. The lipid-conjugated CDV, brincidofovir (BCV), is characterized by a lack of nephrotoxicity, as well as superior activity compared to CDV. The objectives of this study were to examine
Kyounghee Seo   +4 more
openaire   +1 more source

Brincidofovir

Reactions Weekly, 2016
openaire   +2 more sources

Brincidofovir

Reactions Weekly, 2018
openaire   +2 more sources

Brincidofovir

Reactions Weekly, 2017
openaire   +2 more sources

Brincidofovir/cidofovir

Reactions Weekly, 2023
openaire   +1 more source

Brincidofovir

Reactions Weekly, 2015
openaire   +1 more source

Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study

Annals of Otology, Rhinology and Laryngology, 2021
Brent E Richardson
exaly  

FORMULATIONS OF BRINCIDOFOVIR

2023
KABIR MOHAMMED ANOWRUL   +2 more
openaire   +3 more sources

Brincidofovir - Finally an Option for PML?

The Journal of Heart and Lung Transplantation, 2018
J.A. Schneider   +2 more
openaire   +1 more source

Cidofovir/Brincidofovir

Reactions Weekly, 2018
openaire   +1 more source

Home - About - Disclaimer - Privacy